ACRS - Latest News
Aclaris Therapeutics, Inc. (ACRS), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $603.0M. Beta to the broader market is 0.80.
The article list below shows the most recent ACRS headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent ACRS Headlines
Strength Seen in Aclaris (ACRS): Can Its 5.4% Jump Turn into More Strength?
zacks.com - Jul 1, 2026
Aclaris (ACRS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the
3 Penny Stocks Under $5 Backed by Real Revenue Growth
marketbeat.com - Jun 23, 2026
Investing in penny stocks requires significant conviction. Many of the companies in this group are purely “story stocks.
3 Penny Stocks Under $5 Backed by Real Revenue Growth
marketbeat.com - Jun 20, 2026
Investing in penny stocks requires significant conviction. Many of the companies in this group are purely “story stocks.
Aclaris Therapeutics Maps Busy Pipeline Calendar, Plans Phase 2 Asthma Trial for ATI-052
marketbeat.com - Jun 4, 2026
Aclaris Therapeutics NASDAQ: ACRS executives outlined a busy clinical calendar for the biotechnology company during a fireside chat at the Jefferies 2
Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
globenewswire.com - May 28, 2026
WAYNE, Pa. , May 28, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc.
How News Affects ACRS Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ACRS's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked ACRS news questions
- What is the latest ACRS news headline?
- The most recent ACRS headline (Jul 1, 2026) is "Strength Seen in Aclaris (ACRS): Can Its 5.4% Jump Turn into More Strength?". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the ACRS news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What ACRS news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual ACRS options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.